Industry News

Using proprietary technology, ActiveRADAR identifies the lowest cost prescription options. Options that are clinically correct and therapeutically equivalent to Brand and Generic drug alternatives. We help plan members transition to lower cost, therapeutic equivalents, delivering immediate savings to them and their plan sponsors.

ActiveRADAR is addressing the pricing issue head on, going well beyond standard generic substitution. Our technology identifies lower cost substitutions that are therapeutically equivalent, meaning they have the same effect in the treatment of a disease or condition but contain a different active ingredient.

With a current growing database of over 65 different therapeutic classes of drugs, we are creating an environment of choice that builds an improved dialogue between physicians and patients and facilitates informed and medically directed prescription decisions.

Read this article from The Actuary examining the potential savings that can obtain when using reference pricing.

https://www.actuary.org/sites/default/files/files/publications/ReferencePricing_11.2018.pdf